Clinical Trial Update: Leptin: A Marker for AML Chemo-Sensitivity

View source ↗

Summary

The trial assesses whether leptin can serve as a biomarker for chemotherapy sensitivity in adults with acute myeloid leukemia, and the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: AML, Adult | Status: RECRUITING